Skin cancer specialists at M. D. Anderson Cancer Center Orlando are recruiting patients into a large Phase 3 study to evaluate the safety and effectiveness of Allovectin-7(R), an investigational product for advanced melanoma. If Allovectin-7(R) is found to be safe and effective in clinical trials, it may offer patients a new option for fighting advanced melanoma (stage 3 or stage 4). [click link for full article]